Related Experiment Video
Updated: Jul 19, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
Xanthogranulomatous pyelonephritis: our experience with review of published reports
Udai S Dwivedi1, Neeraj K Goyal, Vaibhav Saxena
1Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. usd12@sify.co.in
Background:
The aim of this study was to analyse the cases of xanthogranulomatous pyelonephritis with review of published reports.
Methods:
We retrospectively reviewed all nephrectomy specimens during February 1995 to January 2006. We found 26 cases of xanthogranulomatous pyelonephritis. We prepared a chart of these cases consisting of preoperative symptoms, laboratory findings, radiological imaging results and preoperative diagnosis. Open nephrectomy was carried out in all cases.
Results:
Age group of the patients was 6-65 years and male : female ratio was 1.6:1. Twenty-two patients presented to us with intermittent high-grade fever, 21 with flank pain, 18 with loin mass, 2 with haematuria and 1 was detected during screening of vague gastrointestinal symptoms. Twenty-five patients had pyuria and only 10 had sterile urine culture. In all patients, only one kidney was affected. All patients had renal calculi 10-42 mm in size with bilaterally enlarged kidneys. Ipsilateral kidney was enlarged because of hydronephrosis or pyonephrosis in all cases and contralateral kidney was enlarged because of compensatory hypertrophy in 13 cases. Ipsilateral kidney had severely compromised renal function in all cases. Associated psoas abscess was present in one and tuberculosis in another.
Conclusion:
Xanthogranulomatous pyelonephritis is a relatively rare entity that is associated with obstruction, stones and infection of the urinary tract. Late presentation leads to loss of renal parenchyma. It cannot be differentiated preoperatively with renal tumours (renal cell carcinoma and Wilms' tumour), pyonephrosis, infected hydronephrosis and renal lymphoma. Nephrectomy and antibiotics are the treatment of choice.
Insights
Xanthogranulomatous pyelonephritis (XGP) is a rare kidney infection often linked to obstruction and stones. Early diagnosis is crucial to prevent kidney damage, as XGP can mimic tumors and other infections.
Area of Science:
- Nephrology
- Urology
- Pathology
Background:
- Xanthogranulomatous pyelonephritis (XGP) is a rare, chronic destructive inflammation of the kidney.
- It is often associated with urinary tract obstruction, infection, and renal calculi.
- Differentiating XGP from renal tumors preoperatively can be challenging.
Purpose of the Study:
- To analyze cases of xanthogranulomatous pyelonephritis.
- To review published reports on XGP.
- To understand the clinical presentation, diagnosis, and management of XGP.
Main Methods:
- Retrospective review of nephrectomy specimens from February 1995 to January 2006.
- Analysis of 26 identified cases of XGP.
- Compilation of patient data including symptoms, lab findings, imaging, and preoperative diagnosis; all cases underwent open nephrectomy.
Main Results:
- The study included 26 patients (age 6-65, male:female ratio 1.6:1).
- Common symptoms included fever (22), flank pain (21), and loin mass (18).
- All affected kidneys showed hydronephrosis/pyonephrosis, renal calculi (10-42 mm), and compromised function; 13 had contralateral compensatory hypertrophy. Associated psoas abscess (1) and tuberculosis (1) were noted.
Conclusions:
- Xanthogranulomatous pyelonephritis is a rare condition associated with obstruction, stones, and urinary tract infection.
- Late presentation results in significant renal parenchyma loss.
- Nephrectomy and antibiotics are the recommended treatment, as preoperative differentiation from renal tumors, pyonephrosis, or lymphoma is difficult.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urinary Tract Infection II: Pathophysiology